From journals and scientific sources

318 topics in this forum

1. Primary sources for data, records, papers

   By Altostrata, May 1, 2011
   • 11 replies
   • 2,910 views
   • 
   • Itzakadoozee
   • May 12

2. Important topics in Journals and Scientific Sources

   By Altostrata, May 12, 2011
   • 3 replies
   • 2,935 views
   • 
   • Altostrata
   • January 5

3. Papers about prolonged antidepressant withdrawal syndrome

   By Altostrata, May 22, 2011
   • 30 replies
   • 10,211 views
   • 
   • WiggleIt
   • November 6, 2018

4. Liver Enzymes Cytochrome P450 Drug Interaction Tables

   By Altostrata, November 17, 2011
   • 6 replies
   • 7,201 views
   • 
   • Altostrata
   • July 23, 2018

5. Official guides to tapering off psychiatric medications

   By Altostrata, December 24, 2012
   • 0 replies
   • 3,326 views
   • 
   • Altostrata
   • December 24, 2012

6. Before you start a topic in Journals....

   By Altostrata, June 29, 2012
   • 0 replies
   • 1,752 views
   • 
   • Altostrata
   • June 29, 2012

7. Munkholm Munkholm, 2019, Considering the methodological limitations in the evidence base of antidepressants for depression: a reanalysis of a network meta-analysis

   By Linus, July 1
   • 3 replies
   • 125 views
   • 
   • Linus
   • Saturday at 11:26 AM

8. Horowitz, 2019 Tapering of SSRI treatment to mitigate withdrawal symptoms

   By Henosis, March 6
   • 22 replies
   • 1,399 views
   • 
   • MissyE
   • July 4

9. Ruhe, 2019 Comment on Horowitz, 2019 Tapering of SSRI treatment to mitigate withdrawal symptoms

   By Onmyway, June 28   

   • lancet psychiatry
   • new tapering proposal
   • (and 1 more)

     Tagged with:

     • lancet psychiatry
     • new tapering proposal
     • horrowitz and taylor response
   • 7 replies
   • 126 views
   • 
   • kayjaydee
   • June 29

10. Papers by Dr. GA Fava, long-time critic of antidepressants

    By Altostrata, June 8, 2011
    • 10 replies
    • 7,776 views
    • 
    • Shep
    • June 28

11. Fava, 2017 The Potential Role of Iatrogenic Comorbidity in the Interaction between Pharmacotherapy and Psychotherapy in Anxiety Disorders

    By Shep, June 28
    • 0 replies
    • 53 views
    • 
    • Shep
    • June 28

12. Fava, 2019 Iatrogenic Factors in Psychopathology

    By Shep, June 25
    • 0 replies
    • 84 views
    • 
    • Shep
    • June 25

13. Baldessarin, 2019 Effects of Treatment Discontinuation in Clinical Psychopharmacology.

    By Itzakadoozee, May 12
    • 5 replies
    • 330 views
    • 
    • Itzakadoozee
    • May 21

14. Khan, 2019 Serotonin Sensitivity and Withdrawal With Low-Dose Venlafaxine

    By Altostrata, April 9
    • 0 replies
    • 387 views
    • 
    • Altostrata
    • April 9

15. Moncrieff, 2005 Rethinking models of psychotropic drug action.

    By Altostrata, April 6
    • 0 replies
    • 153 views
    • 
    • Altostrata
    • April 6

16. Aydemir, 2018 SSRI Induced Apathy Syndrome

    By Altostrata, March 1
    • 1 reply
    • 220 views
    • 
    • ShiningLight
    • April 6

17. Récalt, 2019 Withdrawal Confounding in Randomized Controlled Trials of Antipsychotic, Antidepressant, and Stimulant Drugs, 2000-2017.

    By Altostrata, March 27
    • 0 replies
    • 166 views
    • 
    • Altostrata
    • March 27

18. Kanwaldeep, 2008 Watch for nonpsychotropics causing psychiatric side effects 1 2

    By btdt, April 23, 2014
    • 58 replies
    • 3,796 views
    • 
    • ghm2018
    • March 11

19. Veltri, 2015 Medication-induced hypokalemia

    By Altostrata, March 4
    • 0 replies
    • 72 views
    • 
    • Altostrata
    • March 4

20. Oehrberg, 1995 Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study.

    By Altostrata, January 27
    • 0 replies
    • 100 views
    • 
    • Altostrata
    • January 27

21. Andrews, 2012 Primum non nocere: an evolutionary analysis of whether antidepressants do more harm than good

    By Altostrata, April 25, 2012
    • 17 replies
    • 1,497 views
    • 
    • Altostrata
    • January 26

22. Maund, 2019 Managing Antidepressant Discontinuation: A Systematic Review.

    By Altostrata, January 26
    • 0 replies
    • 166 views
    • 
    • Altostrata
    • January 26

23. Papers about Post-SSRI Sexual Disorder (PSSD) 1 2

    By Altostrata, July 5, 2011   

    • pssd
    • sexual dysfunction
    • 36 replies
    • 17,033 views
    • 
    • Altostrata
    • January 19

24. Reisman, 2017 Sexual Consequences of Post-SSRI Syndrome.

    By Altostrata, January 19   

    • pssd
    • sexual dysfunction
    • 0 replies
    • 96 views
    • 
    • Altostrata
    • January 19

25. Bala, 2018 Post-SSRI Sexual Dysfunction: A Literature Review.

    By Altostrata, January 19   

    • pssd
    • sexual dysfunction
    • 0 replies
    • 114 views
    • 
    • Altostrata
    • January 19

26. Papp, 2018 Brain Zaps: An Underappreciated Symptom of Antidepressant Discontinuation.

    By Altostrata, January 5
    • 3 replies
    • 245 views
    • 
    • Linus
    • January 16

27. Harvey, 2014 New insights on antidepressant discontinuation syndrome

    By dalsaan, January 6, 2015
    • 2 replies
    • 936 views
    • 
    • Linus
    • January 16

28. Attfield, 2016 Preparation of Lower Dosages of SNRI Antidepressants to Ameliorate Discontinuation Symptoms: Two Case Studies

    By Andie, December 16, 2018   

    • snri
    • compounding
    • (and 5 more)

      Tagged with:

      • snri
      • compounding
      • pristiq
      • cymbalta
      • desvelafaxine
      • duloxetine
      • venlafaxine
    • 1 reply
    • 152 views
    • 
    • Altostrata
    • January 5

29. Khan, 2014 Abrupt discontinuation compared with a 1-week taper regimen in depressed outpatients treated for 24 weeks with desvenlafaxine 50 mg/d.

    By Altostrata, January 5
    • 0 replies
    • 92 views
    • 
    • Altostrata
    • January 5

30. Eveleigh, 2017 Withdrawal of unnecessary antidepressant medication: a randomised controlled trial in primary care

    By Shep, November 19, 2017
    • 14 replies
    • 981 views
    • 
    • Altostrata
    • January 5

31. Frankel, 2018 An open-label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (R)-(-)-O-desmethylvenlafaxine and racemic O-desmethylvenlafaxine.

    By Andie, December 18, 2018   

    • sert
    • pristiq
    • (and 1 more)

      Tagged with:

      • sert
      • pristiq
      • desvenlafaxine
    • 2 replies
    • 177 views
    • 
    • Altostrata
    • January 5

32. Berwian, 2017 Predicting relapse after antidepressant withdrawal - a systematic review.

    By Altostrata, September 11, 2018
    • 5 replies
    • 309 views
    • 
    • Altostrata
    • January 1

33. Jha, 2018 When Discontinuing SSRI Antidepressants Is a Challenge: Management Tips.

    By Altostrata, December 31, 2018
    • 0 replies
    • 219 views
    • 
    • Altostrata
    • December 31, 2018

34. Fornaro, 2018 The Emergence of loss of efficacy during Antidepressant Drug Treatment for Major Depressive Disorder: An Integrative Review of Evidence, Mechanisms, and Clinical Implications.

    By Altostrata, November 3, 2018   

    • tachyphylaxis
    • poop-out
    • (and 2 more)

      Tagged with:

      • tachyphylaxis
      • poop-out
      • breakthrough symptoms
      • tolerance
    • 1 reply
    • 166 views
    • 
    • Linus
    • December 22, 2018

35. Kaufmann, 2009 Selective Serotonin Reuptake Inhibitor (SSRI) Drugs: More Risks Than Benefits?

    By Altostrata, December 7, 2018
    • 0 replies
    • 172 views
    • 
    • Altostrata
    • December 7, 2018

36. Davies, 2018 A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?

    By Altostrata, October 29, 2018
    • 2 replies
    • 419 views
    • 
    • Bunyapine
    • November 3, 2018